FDA Inspection 1330946 — AVEVA Drug Delivery Systems, Inc.

AVEVA Drug Delivery Systems, Inc. — FEI 1000307689

The FDA completed an inspection of AVEVA Drug Delivery Systems, Inc. on Aug 14, 2026 in Miramar, FL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Aug 14, 2026
Fiscal Year
2026
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Miramar, FL (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
183321 CFR 211.84(d)(1)Identity Testing of Each Component
22921FDCA 582(b)(4)Systems in place to comply with verification requirements

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.